IDH1 and neoplasm: There was a significant correlation between MET uptake and tumor cell count (MET-IDH1: r = 0.44; p = 0.0371), proliferation count (MET-Ki67: r = 0.69; p = 0.0095), and vessel count (MET-CD34: r = 0.67; p = 0.0005).